Navigation Links
Findings from Two Phase 3 Studies of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
Date:4/23/2013

criteria to stop treatment at 24 weeks, 91 percent (QUEST-1) and 86 percent (QUEST-2) of patients achieved SVR12.

"Given the long-term health risks associated with hepatitis C, it's important that physicians and patients have multiple options to treat the disease," said Ira Jacobson , M.D., chief of the Division of Gastroenterology and Hepatology, Vincent Astor Distinguished Professor of Medicine, Weill Cornell Medical College, and attending physician, New York-Presbyterian Hospital/Weill Cornell Medical Center. "The results of these Phase 3 trials suggest that simeprevir could represent an important new treatment option for people living with genotype 1 chronic hepatitis C."

Patients enrolled in QUEST-1 and QUEST-2 were stratified by HCV genotype 1 subtype and IL28B genotype. In QUEST-1, SVR12 rates among patients treated with simeprevir with IL28B genotype variations were 94 percent for the CC allele, 76 percent for the CT allele, and 65 percent for the TT allele. In QUEST-2, SVR12 rates among patients treated with simeprevir with IL28B genotype variations were 96 percent for the CC allele, 80 percent for the CT allele, and 58 percent for the TT allele. Among patients with METAVIR scores F3 and F4, 70 percent of patients treated with simeprevir in QUEST-1 and 66 percent of patients treated with simeprevir in QUEST-2 achieved SVR12. Among patients with METAVIR scores F0 to F2, 83 percent of patients treated with simeprevir in QUEST-1 and 85 percent of patients treated with simeprevir in QUEST-2 achieved SVR12. The METAVIR score is used to quantify the degree of inflammation and fibrosis of the liver and patients are scored on a four-point scale. 

"Patient response rates to hepatitis C therapy can be variable, depending on factors such as viral genotype and subtype, and liver fibrosis. Patients with genotype 1a, IL28B genotype TT and METAVIR scores of F3 and F4 can be particularly c
'/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
2. Dr. Kevin Foley to Present DiscGenics Recent Findings at the Lumbar Spine Research Societys Annual Meeting
3. Professional Therapy Associates Study Supports Findings: Physical Therapy Beneficial in Treating Office Workers with Lower Back Pain
4. HemoShear to Present Translational Findings from its Vascular and Liver Human Relevant Systems
5. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
6. New Findings Offer Systemic Solutions to Address Non-communicable Diseases (NCDs) in Low- and Middle-income Countries
7. Proof of Concept Study Initial Findings
8. French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
9. ENDECE Neural to Present Findings for Remyelination at 2013 Keystone Symposia on Multiple Sclerosis
10. New Findings Link Telehealth-Enabled Care Coordination with Reduced Mortality for Patients with Congestive Heart Failure
11. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, will release its ... Wednesday, March 4, 2015 before the financial markets open.  ... to discuss clinical development progress and financial results for ... 10:00 a.m. Eastern Time on March 4, 2015. ...
(Date:3/2/2015)... 2, 2015  BioMed Realty Trust, Inc. (NYSE: ... 313,000 square feet of space in the most dynamic ... world through the termination of Vertex Pharmaceuticals, leases on ... effective February 28, 2015. BioMed Realty will receive a ... begin to reposition the properties to meet the growing ...
(Date:3/2/2015)... , Abbott Diabetes Care, American Association ... Corp., Apple, Arkray, Asante Solutions, A. Menarini, ... CareFusion, Carewell Biotech, Centres for Medicare and ... Center for Disease Control and Prevention (CDC), ... Pharmaceuticals, Chugai, Conceptus, Covidien, Cygnus, ConvaTec, Constitution ...
Breaking Medicine Technology:Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 3Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2
... and create healthy, pain-free habitsBERKELEY, Calif., May 18 ... The Intelligent Body(R) TMJ Program as ... DIY-series of movement reeducation lessons available on CD. ... inexpensive and effective self-care method to help reduce chronic ...
... Novexel, a speciality pharmaceutical,company focused on the ... the significant global problem of microbial resistance,announces that ... NXL103 are,the subject of four posters at the ... (ECCMID). The ECCMID conference is,taking place in Helsinki ...
Cached Medicine Technology:Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 2Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 3Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 2Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 3
(Date:3/2/2015)... March 02, 2015 Atlantic Information Services, ... AIS’s Directory of Health Plans: 2015 , the ... on the U.S. health plan market, with enrollment data ... United States. , Available as a printed book ... enrollment trends in quick-view tables and charts, as well ...
(Date:3/2/2015)... La Quinta, CA (PRWEB) March 02, 2015 ... All Trades”—Jack Eadon, leader of the 1960s cult rock band ... is fueled by his determination to persevere despite all odds. ... Make It,” no matter what situation or goal was before ... of the ’60s, is now being passed on to a ...
(Date:3/2/2015)... 02, 2015 The Alliance for Bangladesh ... expert Mark Chubb to serve as chief safety officer. ... and training in Bangladesh and guide remediation efforts in ... “Mark will ensure that the Alliance continues to bring ... for Bangladesh garment workers,” said Alliance Independent Chair Ellen ...
(Date:3/2/2015)... 2015 Éminence Organic Skin Care, the ... excited to announce the launch of the Balance Collection, ... time-saving solution for those with combination skin. The Balancing ... divided jar to separate the products, consists of the ... Balancing Moisturizer Duo, also in a divided jar, contains ...
(Date:3/1/2015)... Clearwater, Florida (PRWEB) March 02, 2015 ... market their services and manage their practices ... offer an integrated all-inclusive solution. The ... development program and a medical practice management ... success and long-term financial sustainability. A referral ...
Breaking Medicine News(10 mins):Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4
... ... artificial sweetener Xylitol, consumers can help to prevent cavities. , ... Delray Beach, FL (PRWEB) July 8, 2009 -- Cavities are ... check-ups, a good way to prevent them, according to Delray Beach, Florida-based dentist Dr. Craig ...
... , TAMPA, Fla., July 7 Intelident Solutions, Inc. ("Intelident") today ... Directors of Zila, Inc. (Nasdaq: ZILA ) to acquire ... and the preferred stock for $0.48 per share, or a total ... premium for common stockholders of more than $418,000, or 10.5%, over ...
... Today, the Service Employees International Union (SEIU), which represents ... with U.S. District Court to hold the State in contempt ... workers by $2 per hour in defiance of an earlier ... feels it can simply ignore a U.S. District Court ruling," ...
... Cardinal Justin Rigali, Chairman of the U.S. Catholic Bishops, ... for human embryonic stem cell research issued yesterday by ... his statement follows: , , "In April I ... cell research, saying that under these guidelines ,federal tax ...
... associate professor of chemical and biomolecular engineering David Bruce ... (EFRC) funded with $12.5 million from the U.S. Department ... is focused on the development of new catalysts for ... sources. "The scientific research efforts of CALCD, combined ...
... , BALTIMORE, July 7 DaVita Inc. (NYSE: ... services for those diagnosed with chronic kidney disease (CKD), ... award-winning, leadership development and cultural orientation program for new ... DaVita,s commitment to teammate empowerment and engagement are former ...
Cached Medicine News:Health News:South Florida Dentist Dr. Craig Spodak Recommends Artificial Sweetener Xylitol to Help Prevent Cavities 2Health News:Intelident Solutions Proposes to Acquire Zila for $0.42 per share in Cash 2Health News:Contemptible: Governor, State Officials Defy Court Order to Stop Home Care Cuts, Says SEIU 2Health News:Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research 2Health News:DOE funds Clemson University clean energy research 2Health News:DaVita's Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: